| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1471-4159.1992.TB10970.X |
| P698 | PubMed publication ID | 1374119 |
| P2093 | author name string | K. Mikoshiba | |
| T. Kagawa | |||
| K. Ikenaka | |||
| P2860 | cites work | Mutation of the proteolipid protein gene PLP in a human X chromosome-linked myelin disorder | Q24296775 |
| Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene | Q29618347 | ||
| Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin | Q34337961 | ||
| Myelin proteolipid protein gene structure and its regulation of expression in normal and jimpy mutant mice | Q42638631 | ||
| Myelin-specific proteolipid protein is expressed in myelinating Schwann cells but is not incorporated into myelin sheaths | Q44136853 | ||
| Glial conditioned medium enables jimpy oligodendrocytes to express properties of normal oligodendrocytes: production of myelin antigens and membranes | Q44489386 | ||
| Expression of myelin protein genes in Schwann cells | Q45074898 | ||
| An AG----GG transition at a splice site in the myelin proteolipid protein gene in jimpy mice results in the removal of an exon | Q48335699 | ||
| Nucleotide sequences of two mRNAs for rat brain myelin proteolipid protein | Q48375048 | ||
| Myelin deficit in the Jimpy mouse may be due to cellular abnormalities in astroglia | Q59086257 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nerve tissue protein | Q6996861 |
| P304 | page(s) | 2248-2253 | |
| P577 | publication date | 1992-06-01 | |
| P1433 | published in | Journal of Neurochemistry | Q6295643 |
| P1476 | title | Selective expression of DM-20, an alternatively spliced myelin proteolipid protein gene product, in developing nervous system and in nonglial cells | |
| P478 | volume | 58 |
| Q36695370 | A New Family of Transcripts of the Myelin Basic Protein Gene: Expression in Brain and in Immune System |
| Q48480596 | A PLP splicing abnormality is associated with an unusual presentation of PMD. |
| Q36233433 | A myelin proteolipid protein-LacZ fusion protein is developmentally regulated and targeted to the myelin membrane in transgenic mice |
| Q52170605 | A proteolipid protein-specific pre-mRNA (Ppm-1) contains intron 3 and is up-regulated during myelination in the CNS. |
| Q73226838 | Aberrant dendrite growth in central nervous system white matter induced by a mutant proteolipid protein transgene |
| Q73212381 | Abnormal Ca(2+) regulation in oligodendrocytes from the dysmyelinating jimpy mouse |
| Q92538007 | Anti-Myelin Proteolipid Protein Peptide Monoclonal Antibodies Recognize Cell Surface Proteins on Developing Neurons and Inhibit Their Differentiation |
| Q40951500 | Antisilencing: myelin proteolipid protein gene expression in oligodendrocytes is regulated via derepression |
| Q73016640 | Assembly of CNS myelin in the absence of proteolipid protein |
| Q34170562 | Axon-glial interaction in the CNS: what we have learned from mouse models of Pelizaeus-Merzbacher disease. |
| Q59544320 | Chapter 17 Hereditary spastic paraparesis |
| Q71954916 | Conservation of topology, but not conformation, of the proteolipid proteins of the myelin sheath |
| Q40395804 | Contribution of transplantations to the understanding of the role of the PLP gene |
| Q44480890 | Detection of oligodendrocytes in tissue sections using PCR synthesis of digoxigenin-labeled probes |
| Q40781417 | Differential sensitivity in the survival of oligodendrocyte cell lines to overexpression of myelin proteolipid protein gene products |
| Q35931734 | Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice |
| Q48589602 | Early expression of proteolipid protein in human fetal and infantile cerebri |
| Q80825060 | Early neuronal and glial fate restriction of embryonic neural stem cells |
| Q37280371 | Early postnatal proteolipid promoter-expressing progenitors produce multilineage cells in vivo |
| Q71567360 | Epigenetic factors up-regulate expression of myelin proteins in the dysmyelinating jimpy mutant mouse |
| Q34397212 | Expression of members of the proteolipid protein gene family in the developing murine central nervous system |
| Q34368282 | Expression of myelin transcription factor I (MyTI), a "zinc-finger" DNA-binding protein, in developing oligodendrocytes |
| Q41128484 | Fate of developing astrocytes in the optic nerve of the myelin-deficient rat. |
| Q28570153 | Gene expression and oligodendrocyte development in the myelin deficient rat |
| Q35617206 | Getting a GR(i)P on oligodendrocyte development |
| Q40922187 | Glial transplants: an in vivo analysis of extrinsic and intrinsic determinants of dysmyelination in genetic variants |
| Q39152841 | Histological detection of dynamic glial responses in the dysmyelinating Tabby-jimpy mutant brain. |
| Q31402007 | Identification of a new exon in the myelin proteolipid protein gene encoding novel protein isoforms that are restricted to the somata of oligodendrocytes and neurons |
| Q38340068 | In vitro death of jimpy oligodendrocytes: correlation with onset of DM-20/PLP expression and resistance to oligodendrogliotrophic factors |
| Q61855835 | Insertion of proteolipid protein into mitochondria but not DM20 regulates metabolism of cells |
| Q35597565 | Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination |
| Q71664227 | Isolation and identification of proteolipid proteins in jimpy mouse brain |
| Q71343402 | Loss of myelin basic protein cationicity in DM20 transgenic mice is dosage dependent |
| Q48334459 | Maturation-dependent apoptotic cell death of oligodendrocytes in myelin-deficient rats |
| Q36989973 | Microwave and magnetic (M(2) ) proteomics of the experimental autoimmune encephalomyelitis animal model of multiple sclerosis |
| Q40418136 | Molecular genetic analyses of myelin deficiency and cerebellar ataxia. |
| Q31146132 | Mouse NG2+ oligodendrocyte precursors express mRNA for proteolipid protein but not its DM-20 variant: a study of laser microdissection-captured NG2+ cells. |
| Q48380178 | Multiple restricted origin of oligodendrocytes. |
| Q42826232 | Mutant Plp/DM20 cannot be processed to secrete PLP-related oligodendrocyte differentiation/survival factor |
| Q48687176 | Myelin proteolipid DM20: evidence for function independent of myelination |
| Q48477173 | Myelin proteolipid protein (Plp) intron 1 DNA is required to temporally regulate Plp gene expression in the brain |
| Q73087694 | Normal temporal and spatial distribution of oligodendrocyte progenitors in the myelin-deficient (md) rat |
| Q59782506 | Oligodendrocyte development and differentiation in the rumpshaker mutation |
| Q52196552 | Oligodendrocyte gene expression in the human fetal spinal cord during the second trimester of gestation. |
| Q40518549 | Oligodendrocytes and myelin. |
| Q41144849 | Origin of oligodendrocytes within the human spinal cord |
| Q28300725 | PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2 |
| Q48988108 | Parallel evolution and coexpression of the proteolipid proteins and protein zero in vertebrate myelin |
| Q52124320 | Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. |
| Q77733344 | Proteolipid protein gene modulates viability and phenotype of neurons |
| Q44376577 | Proteolipid protein gene mutation induces altered ventilatory response to hypoxia in the myelin-deficient rat. |
| Q42818708 | Proteolipid protein gene product can be secreted and exhibit biological activity during early development |
| Q48667589 | Proteolipid protein is necessary in peripheral as well as central myelin |
| Q73953692 | Proteolipid protein mRNA stability is regulated by axonal contact in the rodent peripheral nervous system |
| Q41068093 | Regulation of murine myelin proteolipid protein gene expression |
| Q34452653 | STAR, a gene family involved in signal transduction and activation of RNA. |
| Q36553011 | Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy |
| Q41118714 | Temperature-dependent regulation of PLP/DM20 and CNP gene expression in two conditionally-immortalized jimpy oligodendrocyte cell lines |
| Q52168267 | The evolution of lipophilin genes from invertebrates to tetrapods: DM-20 cannot replace proteolipid protein in CNS myelin. |
| Q40488037 | The molecular genetics of myelination: An update |
| Q40402411 | The proteolipid protein gene |
| Q33900243 | The proteolipid protein promoter drives expression outside of the oligodendrocyte lineage during embryonic and early postnatal development |
| Q38361375 | The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins |
| Q77602143 | The up-regulation of stromelysin-1 (MMP-3) in a spontaneously demyelinating transgenic mouse precedes onset of disease |
| Q45732608 | Three new PLP1 splicing mutations demonstrate pathogenic and phenotypic diversity of Pelizaeus-Merzbacher disease. |
| Q43605216 | Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene |
| Q74587444 | Understanding glial abnormalities associated with myelin deficiency in the jimpy mutant mouse |
Search more.